Company - Innovations
Innovations
Since our inception, MIMvista has made a commitment to advancing the health care field. We continually improve and develop our products based on the needs and feedback of our customers. We also pride ourselves on our record of major innovations that have advanced our primary goal of enhancing patient care.
We have recently introduced the VoxAlign Deformation EngineTM. The VoxAlign engine harnesses the power of deformable registration, creating a whole new set of innovative tools for Radiation Oncology, Diagnostic Imaging, and Research.
The MIMvista deformable software has not only streamlined a very laborious but very necessary part of treatment planning; it has allowed easy integration of new imaging technology to better identify areas of active tumor."
Ken Hu, M.D., Radiation Oncologist
Beth Israel Medical Center, New York City
With innovations such as Atlas-based Segmentation, MIMvista offers Radiation Oncologists dramatic time-savings by automatically generating contours for target volumes and normal structures. And Adaptive Re-contouring deforms contours from previous to current planning CTs, making true adaptive radiation therapy practical.
MIMvista has made adaptive replanning of head and neck IMRT cases a feasible standard operating procedure in our department. MIMvista has decreased physician turn-around of approved volumes by a significant amount."
Amy Harrison, Medical Physicist/Clinical Supervisor
Thomas Jefferson University Hospital, Philadelphia
MIMvista has innovated in the areas of PET and PET/CT contouring with PET Edge. This automatic tumor edge detection technique is robust and consistently reproducible, taking the guesswork out of PET contouring. PET Edge, combined with the power of the VoxAlignTM engine for improved alignment of the PET to the Planning CT, means PET/CT confidence is a reality for an increasing number of radiation therapy centers.
In response to the importance of monitoring cancer treatment in both radiology and radiation oncology, MIMvista has added Automated Tools to quickly manage the increased data, accurately correlate tumors across time points, and quantify response to therapy.
I have been using MIM for PET/CT reviews for a few years now, and find it far superior to several other PET/CT review platforms I have used. MIM outperforms other platforms when it comes to the follow-up of cancer patients for assessment of interval change after therapy. The 3D volumetric tumor analysis for more accurate assessment of global tumor change is surprisingly easy to use and accurately reproducible."
Munir Ghesani, M.D., Nuclear Medicine Physician
St. Luke's - Roosevelt Hospital Center, New York City
Surgical intervention for epilepsy requires accurate localization of the epileptic focus. Typically, the most difficult cases require ictal/interictal SPECT analysis. MIMvista has automated and enhanced this cumbersome process with the MIM Epilepsy Analysis Workflow. The Workflow creates an analysis that is reproducible and accurate; and ensures clarity in interpretation and communication with the surgical and neurological team.
The (MIM epilepsy) workflow significantly reduces processing time by our technologists; from hours to minutes. Indeed, I can quickly process the data myself, which makes me independent of technologist availability. I can read the study when I'm ready, not when it’s ready. The workflow is useful especially for extratemporal epilepsy. In particular, the cluster analysis increases my diagnostic confidence. It is also helpful to show the epilepsy localization to my neurosurgery and neurology colleagues."
Peter Faulhaber, M.D., Director, Clinical PET
University Hospitals of Cleveland
Case Western Reserve University Medical Center
As new therapeutic options are evaluated for Alzheimer’s Disease and other neurological disorders, tracers for PET and SPECT Neuroimaging have been a focus of recent development. MIMneuro provides an intuitive interface for quantitative evaluation. Without sacrificing the flexibility and power required for clinical trials, it is an essential link between development and clinical use of novel tracers.
We are doing twice as many Neuro PET exams as we did a year ago. This is a direct result of the quantitative capability of MIMneuro which allows us to generate more definitive reports that our clinicians have confidence in. MIMneuro is an enormous tool for neuro PET, and in my opinion an obligatory tool. I have increased confidence using PET for tumor evaluation in the brain since MIMneuro can detect changes in metabolic expression which may not be visually conspicuous in the context of intense cortical uptake."
Larry McNamee, M.D., Medical Director
Specialty Teleradiology, Westlake, Ohio
At MIMvista, we are also innovating in the PACS arena with the MIM Storage Server. The increased storage demands of Image-Guided Radiation Therapy (IGRT) have created the need for an RT-PACS that handles both traditional modalities and RT formats. The MIM Storage Server leverages the power of MIM’s diagnostic display and contouring software to create the first image-centric RT-PACS solution. Finally, data for planning, daily setup, replanning, and retreatment for tumor recurrence can be quickly and easily accessed, enabling increased productivity and enhanced patient care.